Literature DB >> 21689880

Prevalence of radiological and clinical cerebrovascular disease in idiopathic Parkinson's disease.

M Patel1, C Coutinho, H C A Emsley.   

Abstract

Comorbid cerebrovascular disease (CVD) can occur in idiopathic Parkinson's disease (IPD) but its reported prevalence varies considerably. CVD may alter the clinical presentation, course and prognosis in IPD. We aimed to determine the prevalence of radiological and clinical CVD in a neurology clinic IPD population. We undertook a retrospective case-control study of neurology clinic patients with IPD for whom cerebral imaging was available, and excluding probable vascular parkinsonism. IPD diagnosis was validated against UK PDS brain bank criteria. Age and sex-matched controls were identified from patients attending neurology clinics with headache. The presence of radiological cerebrovascular disease, symptomatic CVD (stroke and TIA), and CVD risk factors was recorded for cases and controls. Radiological findings were validated by an experienced consultant neuroradiologist using a structured proforma. Eighty-five cases and 85 controls were studied, based on the number of cases for whom brain imaging existed (CT in 50, MRI in 35) and the number of cases for whom suitable controls could be identified. Indications for brain imaging amongst cases were varied. Cases and controls comprised 55(65%) males, mean (± SD) age (years) 67.4 ± 10.1 (cases), 66.6 ± 9.9 (controls). Radiological CVD was significantly commoner amongst cases (39%) than controls (22%) (p=0.02, chi-square; odds ratio 2.2, 95% CI: 1.1-4.6). Cases also had significantly more symptomatic CVD, but not CVD risk factors, than controls. Our findings suggest a higher prevalence of radiological and clinical CVD in patients with IPD compared to controls.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21689880     DOI: 10.1016/j.clineuro.2011.05.014

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  6 in total

1.  Structural and physiological neurovascular changes in idiopathic Parkinson's disease and its clinical phenotypes.

Authors:  Sarah Al-Bachari; Rishma Vidyasagar; Hedley Ca Emsley; Laura M Parkes
Journal:  J Cereb Blood Flow Metab       Date:  2017-01-23       Impact factor: 6.200

2.  Neuroimaging cerebrovascular biomarkers in Parkinson's disease.

Authors:  Mariana Alves; Patrícia Pita Lobo; Linda Azevedo Kauppila; Leonor Rebordão; M Manuela Cruz; Carla Guerreiro; José M Ferro; Joaquim J Ferreira; Sofia Reimão
Journal:  Neuroradiol J       Date:  2021-12-06

3.  Prevalent cerebrovascular and cardiovascular disease in people with Parkinson's disease: a meta-analysis.

Authors:  Lung Chan; Chyi-Huey Bai; Chien Tai Hong; Han-Hwa Hu
Journal:  Clin Epidemiol       Date:  2018-09-04       Impact factor: 4.790

Review 4.  Management of dysphagia and gastroparesis in Parkinson's disease in real-world clinical practice - Balancing pharmacological and non-pharmacological approaches.

Authors:  Roongroj Bhidayasiri; Warongporn Phuenpathom; Ai Huey Tan; Valentina Leta; Saisamorn Phumphid; K Ray Chaudhuri; Pramod Kumar Pal
Journal:  Front Aging Neurosci       Date:  2022-08-11       Impact factor: 5.702

Review 5.  Recovery Potential After Acute Stroke.

Authors:  Rüdiger J Seitz; Geoffrey A Donnan
Journal:  Front Neurol       Date:  2015-11-11       Impact factor: 4.003

6.  Vascular Parkinsonism sensitive to Rotigotine therapy is found in aged patients: a clinical case description.

Authors:  Flora Zarola
Journal:  Acta Biomed       Date:  2018-03-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.